COSMAX INC
✅ Low Risk
FEI: 3015197916 • Seongnam-Si • SOUTH KOREA
FEI Number
3015197916
Location
Seongnam-Si
Country
SOUTH KOREAAddress
401 E Dong Pangyo Innov, , Seongnam-Si, , South Korea
Low Risk
FDA Import Risk Assessment
This firm has a minimal history of FDA import refusals with low-severity violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
CSTIC LBLG
The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 4/24/2019 | 53CC04EYE LOTION (EYE MAKEUP PREPARATIONS) | 471CSTIC LBLG | Division of Southeast Imports (DSEI) |
Frequently Asked Questions
What is COSMAX INC's FDA import refusal history?
COSMAX INC (FEI: 3015197916) has 1 FDA import refusal record(s) in our database, spanning from 4/24/2019 to 4/24/2019.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. COSMAX INC's FEI number is 3015197916.
What types of violations has COSMAX INC received?
COSMAX INC has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about COSMAX INC come from?
All FDA import refusal data for COSMAX INC is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.